Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis

NCT04032743 ·Status: UNKNOWN

Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia

NCT04037189 ·Status: UNKNOWN

Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia

NCT01688752 ·Status: WITHDRAWN

Multi-centre Prospective Cohort of Childhood Leukaemia: Determinants of Health and Quality of Life of the Patients After Treatment for an Acute Leukaemia During Childhood or Adolescence - LEA

NCT01756599 ·Status: UNKNOWN ·Phase: NA

Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study

NCT01565447 ·Status: COMPLETED

"LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia

NCT02074657 ·Status: COMPLETED ·Phase: PHASE2

Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes

NCT02675166 ·Status: COMPLETED

Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children

NCT04659733 ·Status: UNKNOWN ·Phase: PHASE1

LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

NCT05058508 ·Status: RECRUITING ·Phase: NA

Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors

NCT00607984 ·Status: UNKNOWN ·Phase: NA

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

NCT01225419 ·Status: COMPLETED ·Phase: PHASE2

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

NCT04320888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]

NCT03686566 ·Status: COMPLETED

Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

NCT01944982 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia

NCT01678508 ·Status: COMPLETED

Quality of Life in Children Cured of Retinoblastoma

NCT00278031 ·Status: UNKNOWN

Trabectedin and Irinotecan for Refractory Pediatric Sarcomas

NCT02509234 ·Status: UNKNOWN

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

NCT05120518 ·Status: RECRUITING

Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)

NCT01329471 ·Status: UNKNOWN

Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas

NCT02409576 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

NCT06184009 ·Status: RECRUITING ·Phase: PHASE2

Tissue Study of Bv8/PK-2 Inhibition in Human Cancer

NCT01656824 ·Status: UNKNOWN

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors

NCT04774718 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

NCT04478292 ·Status: RECRUITING ·Phase: PHASE3

Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study

NCT02557243 ·Status: COMPLETED